126 related articles for article (PubMed ID: 11583814)
1. A new functional domain of Bcl6 family that recruits histone deacetylases.
Zhang H; Okada S; Hatano M; Okabe S; Tokuhisa T
Biochim Biophys Acta; 2001 Sep; 1540(3):188-200. PubMed ID: 11583814
[TBL] [Abstract][Full Text] [Related]
2. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
[TBL] [Abstract][Full Text] [Related]
3. Bcl6-dependent transcriptional repression by BAZF.
Takenaga M; Hatano M; Takamori M; Yamashita Y; Okada S; Kuroda Y; Tokuhisa T
Biochem Biophys Res Commun; 2003 Apr; 303(2):600-8. PubMed ID: 12659862
[TBL] [Abstract][Full Text] [Related]
4. BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor.
Okabe S; Fukuda T; Ishibashi K; Kojima S; Okada S; Hatano M; Ebara M; Saisho H; Tokuhisa T
Mol Cell Biol; 1998 Jul; 18(7):4235-44. PubMed ID: 9632807
[TBL] [Abstract][Full Text] [Related]
5. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.
Dhordain P; Albagli O; Lin RJ; Ansieau S; Quief S; Leutz A; Kerckaert JP; Evans RM; Leprince D
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10762-7. PubMed ID: 9380707
[TBL] [Abstract][Full Text] [Related]
6. Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor.
Lemercier C; Brocard MP; Puvion-Dutilleul F; Kao HY; Albagli O; Khochbin S
J Biol Chem; 2002 Jun; 277(24):22045-52. PubMed ID: 11929873
[TBL] [Abstract][Full Text] [Related]
7. Acetylation inactivates the transcriptional repressor BCL6.
Bereshchenko OR; Gu W; Dalla-Favera R
Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
[TBL] [Abstract][Full Text] [Related]
8. The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo.
Dhordain P; Albagli O; Ansieau S; Koken MH; Deweindt C; Quief S; Lantoine D; Leutz A; Kerckaert JP; Leprince D
Oncogene; 1995 Dec; 11(12):2689-97. PubMed ID: 8545127
[TBL] [Abstract][Full Text] [Related]
9. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
10. Point mutations in BCL6 DNA-binding domain reveal distinct roles for the six zinc fingers.
Mascle X; Albagli O; Lemercier C
Biochem Biophys Res Commun; 2003 Jan; 300(2):391-6. PubMed ID: 12504096
[TBL] [Abstract][Full Text] [Related]
11. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.
Chang CC; Ye BH; Chaganti RS; Dalla-Favera R
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6947-52. PubMed ID: 8692924
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional repression by the proto-oncogene BCL-6.
Seyfert VL; Allman D; He Y; Staudt LM
Oncogene; 1996 Jun; 12(11):2331-42. PubMed ID: 8649773
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of the human BAZF gene, a homologue of the BCL6 oncogene.
Sakashita C; Fukuda T; Okabe S; Kobayashi H; Hirosawa S; Tokuhisa T; Miyasaka N; Miura O; Miki T
Biochem Biophys Res Commun; 2002 Mar; 291(3):567-73. PubMed ID: 11855826
[TBL] [Abstract][Full Text] [Related]
14. Bcl6 is a transcriptional repressor for the IL-18 gene.
Takeda N; Arima M; Tsuruoka N; Okada S; Hatano M; Sakamoto A; Kohno Y; Tokuhisa T
J Immunol; 2003 Jul; 171(1):426-31. PubMed ID: 12817026
[TBL] [Abstract][Full Text] [Related]
15. Backbone resonance assignment of the BCL6-BTB/POZ domain.
Lin LY; Evans SE; Fairall L; Schwabe JWR; Wagner SD; Muskett FW
Biomol NMR Assign; 2018 Apr; 12(1):47-50. PubMed ID: 28929458
[TBL] [Abstract][Full Text] [Related]
16. A putative silencer element in the IL-5 gene recognized by Bcl6.
Arima M; Toyama H; Ichii H; Kojima S; Okada S; Hatano M; Cheng G; Kubo M; Fukuda T; Tokuhisa T
J Immunol; 2002 Jul; 169(2):829-36. PubMed ID: 12097386
[TBL] [Abstract][Full Text] [Related]
17. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression.
Dhordain P; Lin RJ; Quief S; Lantoine D; Kerckaert JP; Evans RM; Albagli O
Nucleic Acids Res; 1998 Oct; 26(20):4645-51. PubMed ID: 9753732
[TBL] [Abstract][Full Text] [Related]
18. Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product.
Nakamura T; Yamazaki Y; Saiki Y; Moriyama M; Largaespada DA; Jenkins NA; Copeland NG
Mol Cell Biol; 2000 May; 20(9):3178-86. PubMed ID: 10757802
[TBL] [Abstract][Full Text] [Related]
19. BCoR, a novel corepressor involved in BCL-6 repression.
Huynh KD; Fischle W; Verdin E; Bardwell VJ
Genes Dev; 2000 Jul; 14(14):1810-23. PubMed ID: 10898795
[TBL] [Abstract][Full Text] [Related]
20. Binding of BAZF and Bc16 to STAT6-binding DNA sequences.
Hartatik T; Okada S; Okabe S; Arima M; Hatano M; Tokuhisa T
Biochem Biophys Res Commun; 2001 Jun; 284(1):26-32. PubMed ID: 11374866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
